NexPulse AI Inc. is spearheading the quantum AI revolution with QuantumPulse AI, a $25M–$60M platform backed by a provisional patent (16 figures). Powered by Qiskit/Cirq and PyTorch, it achieves 5–10x faster simulations and 20–30% higher accuracy than competitors like Gaussian, ROS, or AlphaFold across chemistry, robotics, engineering, physics, finance, biology, medicine, and motion analysis. Our five patent-pending innovations include: a no-code NLP interface enabling non-expert queries like “Simulate Alzheimer’s drug binding” (70% faster setup); quantum backend selection optimizing across AWS Braket, Microsoft Azure Quantum, and Google Cloud with IonQ’s #AQ 64 (25% lower latency); reflexive memory architecture reducing errors by 40% and iterations by 50%; adaptive quantum solvers with 2–5x faster convergence; and a hybrid quantum-classical pipeline blending DFT and OpenCV. In chemistry, we boost drug discovery 5x with 30% higher hit rates, saving $2.6B per drug. Robotics cuts warehouse costs $10M annually with 60% faster optimization. Medicine improves Parkinson’s diagnostics by 30% via gait/EMG. With 90% test coverage, we scale to 20 qubits (50+ by Q4 2025), targeting $100M revenue by 2028 and a $1T quantum economy by 2035 (McKinsey 2025). Founded by Alex Peter Severson, CEO, contact ceo@nexpulseai.com. Collaborate at research@nexpulseai.com or follow @NexPulseAI on X.